Pharmacy Practice
Affordable Medicines
Biosimilars
Compliance
Compounding
Drug Approvals
Geriatrics
Hospital/Health System
In-Pharmacy Vaccines
Law
Medication Management
News & Trends
OTC
Pharmacist Resources
Specialty Pharmacy
Technology
Disease State
Allergy
Autoimmune
Breast Cancer
Cardiovascular
Cold & Flu
COVID-19
Dermatology
Diabetes
Gastroenterology
Hematology
HIV/AIDS
Infectious Disease
Infusion
Lung Cancer
Mental Health
mRNA Technology
Neurology
Oncology
Ophthalmology
Orthopedics
Pain Management
Pediatrics
Respiratory
Schizophrenia
Urology/Nephrology
Women’s Health
Health Awareness Month
Videos
Patient Teaching Aid
Publications
Featured Issue
Featured Supplements
Conference Coverage
Continuing Education
Subscribe
COVID-19 Resources
March 2022
Digital Magazine
Archives
Subscription
Features
Anticipating the First Adalimumab Biosimilar
Current and Evolving Treatments for HIV PrEP
Managing Acute Pain in Opioid Use Disorder
Pharmacogenomic Considerations in Opioid Therapy
PTA: Psoriatic Arthritis
Vitamins and Minerals for Pain Management
Departments
Clinical News Digest
Pain News Digest
Clinical News Digest
Specialty Pharmacy News Digest
Consult Your Pharmacist
Multiple Sclerosis
Contemporary Compounding
Morphine Sulfate 5 mg/0.1 mL Nasal Solution
Editorial
Large Migraine Study Manifests New Genetic Risk Factors
TrendWatch
Research on Pain Mechanisms and Nondrug Treatment Approaches
X
April 2024
In This Issue
Digital Magazine
Archives
Subscription
Continuing Education
$7.95 Per CE Exam or $69 for 12 Lessons
• April 2026
• 2.00 Credits
Managing HIV Coinfections and Complications
Pain Management
• March 2026
• 2.00 Credits
Updated Guidance for Opioid Use in Pain Management
Cardiovascular
• February 2026
• 2.00 Credits
Managing Modifiable Risk Factors in Chronic Coronary Disease
×
Full Image